Deutsche Bank
FHTX icon

Deutsche Bank’s Foghorn Therapeutics FHTX Stock Holding History

Deutsche Bank’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$178K Buy
36,537
+9,116
+33% +$40.5K ﹤0.01% 3314
2026
Q1 		$131K Hold
27,421
– – ﹤0.01% 3165
2025
Q4 		$148K Buy
27,421
+1,861
+7% +$8.44K ﹤0.01% 3155
2025
Q3 		$125K Buy
25,560
+4,670
+22% +$24.8K ﹤0.01% 3264
2025
Q2 		$98.2K Hold
20,890
– – ﹤0.01% 3267
2025
Q1 		$76.2K Buy
20,890
+8,580
+70% +$39.1K ﹤0.01% 3281
2024
Q4 		$58.1K Hold
12,310
– – ﹤0.01% 3394
2024
Q3 		$115K Buy
12,310
+4,470
+57% +$32.4K ﹤0.01% 3172
2024
Q2 		$45.1K Sell
7,840
-1,754
-18% -$10.4K ﹤0.01% 3342
2024
Q1 		$64.4K Sell
9,594
-399
-4% -$2.21K ﹤0.01% 3334
2023
Q4 		$64.5K Hold
9,993
– – ﹤0.01% 3385
2023
Q3 		$50K Hold
9,993
– – ﹤0.01% 3414
2023
Q2 		$70.4K Sell
9,993
-2,986
-23% -$20.9K ﹤0.01% 3395
2023
Q1 		$80.5K Buy
12,979
+4,340
+50% +$28.4K ﹤0.01% 3415
2022
Q4 		$55.1K Buy
8,639
+136
+2% +$1.03K ﹤0.01% 3539
2022
Q3 		$73K Sell
8,503
-1,345
-14% -$17.3K ﹤0.01% 3463
2022
Q2 		$134K Sell
9,848
-779
-7% -$10.1K ﹤0.01% 3374
2022
Q1 		$162K Sell
10,627
-1,258
-11% -$17.3K ﹤0.01% 3373
2021
Q4 		$272K Sell
11,885
-83,055
-87% -$1.19M ﹤0.01% 3213
2021
Q3 		$1.32M Sell
94,940
-94,169
-50% -$1.04M ﹤0.01% 2429
2021
Q2 		$2.02M Sell
189,109
-33,805
-15% -$368K ﹤0.01% 2210
2021
Q1 		$2.94M Buy
222,914
+217,868
+4,318% +$3.57M ﹤0.01% 1894
2020
Q4 		$102K Buy
+5,046
New +$96.7K ﹤0.01% 3840

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Deutsche Bank's FHTX Position: Q2 2026 in Review

Deutsche Bank increased its Foghorn Therapeutics (FHTX) stake by 33% in Q2 2026, buying an estimated $40.5K and bringing the position to 36,537 shares worth $178K. The position accounts for ﹤0.01% of the portfolio, ranked #3314.

Deutsche Bank first reported a position in FHTX in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.94M in Q1 2021. 103 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • Deutsche Bank held 36,537 shares of Foghorn Therapeutics worth $178K as of Q2 2026.
  • Deutsche Bank bought 9,116 Foghorn Therapeutics shares in Q2 2026, an estimated $40.5K.
  • Foghorn Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3314 holding.
  • Deutsche Bank first reported a position in Foghorn Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • Deutsche Bank's Foghorn Therapeutics position peaked at $2.94M in Q1 2021.
  • 103 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.